|
 |
|
Zoë has a broad practice advising clients across the range of IP rights. She is particularly known for her expertise in advising clients in complex patent disputes. She also assists clients in devising IP and regulatory strategies, providing clients with freedom to operate and product life-cycle management advice.
In addition to representing clients before the UK courts, Zoë regularly appears in European Patent Office opposition proceedings, and has represented clients in arbitration proceedings relating to technology contract disputes. Zoë has been involved in many multi-jurisdictional disputes, working with advisors from across Europe, North America and Japan, and, in many instances, has taken a role in coordinating such litigation. In 2003, Zoë spent 6 months in The Hague seconded to the IP/ICT department of a leading Dutch law firm.
Prior to founding Powell Gilbert in 2007, Zoë was a partner at Bristows. She is a member of AIPPI and EPLAW. She frequently lectures on IP law and is a tutor on the Bristol University Diploma in Intellectual Property Law and Practice. Zoë is currently a contributor to the next edition of the CIPA Guide to the Patents Act.
Zoë was shortlisted for Best Contribution to Copyright Litigation in the WORLDleaders: The European IP Awards 2004 for her work in precedent-setting litigation concerning copy-protection circumvention devices.
Zoë Butler is well regarded for life sciences disputes.
Legal 500
|
|
Contact details
DDI +44 (0)20 3008 8086
E zoe.butler@powellgilbert.com
Qualifications
1996 Solicitor
2007 Solicitor Advocate
Education
MA (Natural Sciences and Law), Cambridge University
Diploma in Intellectual Property Law and Practice, Bristol University
Cases include
• Affymetrix v Illumina (Patent-DNA microarrays)
• Ivax v Chugai (Patent – pharmaceutical formulation)
• Sony Computer Entertainment v. Ball & others (Copyright – Copy protection circumvention devices)
• Affymetrix v Multilyte (Patent – DNA microarrays)
• AstraZeneca v Hässle (Patent – pharmaceutical formulation)
• Allergan v Pharmacia (Patent – glaucoma treatment)
• Oxford Gene Technology v Affymetrix (Patent / licence dispute – DNA microarrays)
• Pharmacia v Merck (Patent – COX 2 inhibitors)
• Iomega v Nomai (Trade mark / passing off – ZIP disc technology)
• IDV v Asda (Trade mark / passing off – drinks market)
• E-UK Controls Ltd’s Licence of Right Application (Design right–control keys)
|
|